Infection latente a M. tuberculosis, mise a jour 2011 [Latent M. tuberculosis infection, update 2011].

Détails

ID Serval
serval:BIB_247DB65224E5
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Infection latente a M. tuberculosis, mise a jour 2011 [Latent M. tuberculosis infection, update 2011].
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Lechartier B., Mazza-Stalder J., Janssens J.P., Nicod L.P.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2011
Volume
7
Numéro
318
Pages
2289-2294
Langue
français
Notes
Publication types: English Abstract ; Evaluation Studies ; Journal Article ; ReviewPublication Status: ppublish
Résumé
It is estimated that one third of the world population is latently infected by Mycobacterium tuberculosis and thus at risk of reactivation. Latent tuberculosis (TB) impact in Switzerland is often overlooked. Diagnosis and prophylaxis are insufficiently undertaken, especially for people at higher risk of reactivation due to immunosuppression. Interferon-gamma release assays replace tuberculosis skin tests for diagnosis of latent infection in adults. It is still recommended to treat prophylactically a case of latent TB infection with 9 months of isoniazid; however therapy with rifampicin for 4 months, currently an alternative option, is linked to improved adherence and favorable cost-benefit ratio.
Mots-clé
Adult, Health Care Costs, Hematologic Tests, Humans, Interferon-gamma Release Tests, Latent Tuberculosis/diagnosis, Latent Tuberculosis/economics, Models, Biological, Mycobacterium tuberculosis/isolation & purification, Tuberculin Test
Pubmed
Création de la notice
31/05/2012 18:49
Dernière modification de la notice
20/08/2019 13:02
Données d'usage